The notorious “drug lag” for oncology drugs in Japan

Author:

Yonemori Kan,Hirakawa Akihiro,Ando Masashi,Hirata Taizo,Yunokawa Mayu,Shimizu Chikako,Katsumata Noriyuki,Tamura Kenji,Fujiwara Yasuhiro

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,Oncology

Reference21 articles.

1. Ministry of Health, Labour and Welfare (2005) The expert review committee for unapproved drugs. Available from URL: http://www.mhlw.go.jp/shingi/2005/01/s0124-9.html [accessed 3 July 2010].

2. Ministry of Health, Labour and Welfare (2006) The expert review committee in order to rapidly supply effective and safe medicines. Available from URL: http://www.mhlw.go.jp/shingi/2006/10/s1030-8.html [accessed 3 July 2010].

3. Fukuhara H (2006) Period between world first launch and country launch. Office of Pharmaceutical Research. Research Paper No. 31, Office of Pharmaceutical Research, Tokyo. (in Japanese)

4. Tsuji K, Tsutani K (2008) Approval of new biopharmaceuticals 1999–2006: comparison of the US, EU and Japan situations. Eur J Pharm Biopharm 68:496–502

5. Farrell AT, Papadouli I, Hori A et al (2006) The advisory process for anticancer drug regulation: a global perspective. Ann Oncol 17:889–896

Cited by 44 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3